Even boosters are a bit of a question in my mind. I had forgotten they were already approved recently. There really ahsn't been much discussion at UCSF about it other than "it's available we're still evaluating data before making recommendations".

What I should have said was "nobody should take the pre-bivalent boosters with any expectation of seeing a reduction in infection chances, or severity of disease, based on our current understanding of omicron, while bivalent boosters seem promising, even though we have extremely limited data and won't know for sure until after the winter cycle."